Interleukin-1-receptor antagonist (IL-1RA) modulates the biological activity of the proinflammatory cytokine interleukin-1 (IL-1) and could play an important role in the pathophysiology of inflammatory and metabolic traits. We genotyped seven single nucleotide polymorphisms (SNPs) that capture a large proportion of common genetic variation in the IL-1RN gene in 1256 participants from the Invecchiare in Chianti study. We identified five SNPs associated with circulating IL-1RA levels with varying degrees of significance (P-value range ¼ 0.016-4.9 Â 10 À5 ). We showed that this association is likely to be driven by one haplotype, most strongly tagged by rs4251961. This variant is only in weak linkage disequilibrium (r 2 ¼ 0.25) with a previously reported variable number of tandem repeats polymorphism (VNTR) in intron-2 although a second variant, rs579543, that tags the VNTR (r 2 ¼ 0.91), may also be independently associated with IL-1RA levels (P ¼ 0.03). We found suggestive evidence that the C allele at rs4251961 that lowers IL-1RA levels is associated with an increased IL-1b (P ¼ 0.03) level and may also be associated with interferon -g (P ¼ 0.03), a-2 macroglobulin (P ¼ 0.008) and adiponectin (P ¼ 0.007) serum levels. In conclusion, common variation across the IL-1RN gene is strongly associated with IL-1RA levels.
Introduction
The cytokine interleukin-1 (IL-1) acts as a major initial inducer of a proinflammatory state. Two structurally different forms (IL-1a and IL-1b) exist, both of which bind to the same receptor protein (IL-1R). The IL-1-receptor antagonist (IL-1RA) binds to this same receptor but does not initiate signal transduction, thus acting as an antagonist to both IL-1a and IL-1b. 1 As IL-1 is expressed in nearly every tissue and organ in response to infection and injury, the hepatic acute-phase production of IL-1RA in response to IL-6 and IL-1b 2 and the expression of the extracellular soluble form of IL-1RA are both important phenomenon for controlling IL-1 activity.
In humans, measurable levels of serum IL-1RA increase with age 3 and are associated with peripheral arterial disease, 4 unstable angina 5 and poorer physical functioning in old age. 6 The biological ability of IL-1RA to downregulate IL-1a and IL-1b activity has led to clinical trials using IL-1RA as an anti-inflammatory agent in conditions including septic shock 7 and rheumatoid arthritis. 8 Despite of their known anti-inflammatory activity, in observational studies, higher IL-1RA levels are associated with acute inflammatory markers such as fibrinogen and C-reactive protein (CRP) in an ageing population. 4 This discrepancy has been interpreted by considering that while IL-1 is produced locally and has a very short half life, IL-1RA is a liver-produced acute-phase reactive protein and has a relatively longer half-life.
Mouse knockout studies of the gene encoding IL-1RA (IL-1RN) produce a phenotype characterized by arterial inflammation 9 and inflammatory autoimmune diseases, 10, 11 thus indicating the important role of this cytokine in inhibiting a spontaneous inflammatory state induced by IL-1. That IL-1RA has the property of inhibiting the induction of the ubiquitous transcription factor NF-kB 12 supports its role in controlling the production of a host of inflammatory markers and mediators including CRP, PAI-1 (plasminogen activator inhibitor-1) IL-6, tumor necrosis factor (TNF)-a and IL-1b. 13 The role of variation in the gene encoding IL-1RA (IL-1RN) is poorly understood. Some genetic studies of the IL-1RN gene have concentrated on a single 86-bp variable number tandem repeat (VNTR) polymorphism in intron-2. This VNTR polymorphism was functionally associated with IL-1RA expression in one study 14 and was recently associated with IL-1RA levels in a population of 1068 men from Sweden 15 (P ¼ 0.005) and a study of 200 healthy blood donors 16 (Po0.05). More comprehensive studies of variation in the IL-1RN gene are needed for several reasons. First, the statistical confidence of previous findings did not reach the stringent levels required for genetic association studies; second, it is not known whether common IL-1RN gene variation other than the VNTR affects serum IL-1RA levels; and third, it is not known whether polymorphisms of the IL-1RN gene are associated with other inflammatory and metabolic markers. Some previous studies have reported that the intron-2 VNTR is associated with disease states including coronary atherosclerosis in diabetic patients, 17 ulcerative colitis and Crohn's disease, 18 yet these results remain inconclusive owing to the small number of cases studied and the lack of robust replications. Common functional variation in the IL-1RN gene may explain some of the variation in inflammatory responses between different individuals and will allow the investigation of the causal direction of associations between IL-1RA and various chronic and acute inflammatory markers often associated with these disease states.
In this study, we use a tag-SNP 19 approach to assess the role of common (minor allele frequency (MAF) 410%) variation in the IL-1RN gene in determining circulating IL-1RA levels. Using data from the Invecchiare in Chianti (InCHIANTI) population-based study of elderly individuals (Table 1) and from HapMap, we aimed to capture a large proportion of common variation across the IL-1RN gene located at position 2q14.2 and assess its association with IL-1RA levels. We investigated the correlation of common variation in the gene with the previously reported VNTR, and finally assessed the association of gene variants altering IL-1RA levels with intermediate inflammatory markers and metabolic traits.
Results
Common variation in the IL-1RN gene and IL-1RA serum concentrations -SNP analyses We successfully genotyped seven SNPs that captured 40 out of 58 SNPs (69%) across IL-1RN at r 2 40. 8 and 43 out of 58 SNPs (77%) at r 2 40.5 (Figure 1 ), where minor allele frequencies were 40.1. Call rates for these SNPs ranged from 85 to 95% and duplication error rates were less than 3% for all SNPs, the mean duplicate error rate being 1.2%. All the typed SNPs were in Hardy-Weinberg equilibrium (P40.01). An eighth SNP (rs973635), the use of which resulted in capturing 84% of common variation across the gene, was only successful in 75% of samples and was therefore not included in the analysis. The positions of the seven typed SNPs and VNTR and their linkage disequilibrium (LD) structure in relation to each other and nongenotyped variation from HapMap is shown in Figure 2 . An overview of the LD pattern between the analyzed tag-SNPs with respect to each other in the InCHIANTI DNA samples is given in Figure 3 . The LD pattern was similar to that seen in the HapMap samples.
The associations between the seven genotyped tagSNPs and serum IL-1RA concentrations are shown in Table 2 . We found that five SNPs were associated with IL-1RA levels with P values ranging from 0.01 to 4.9 Â 10
À5
. The most strongly associated SNP was rs4251961. This association remains after a conservative Bonferroni's correction accounting for the seven SNPs tested (P ¼ 3.4 Â 10
À4
). The second strongest association was observed with rs579543 (P ¼ 2.9 Â 10
). All SNPs associated at Po0.05 were in LD with rs4251961 (r 2 between 0.20 and 0.80).
We found that the minor allele (C) of the most strongly associated SNP, rs4251961, was associated with lower IL-1RA concentrations ( Table 2 ). The difference in mean IL-1RA concentrations observed when comparing individuals homozygous for the C allele with those homozygous for the T allele was 33 pg/ml (95% confidence interval (CI) 16.95-49.04, P ¼ 0.0002) and heterozygous Of the five SNPs associated with IL-1RA levels at Po0.05, the second most significant SNP, rs579543, was correlated with the most significant SNP, rs4251961, with the weakest r 2 value in HapMap (0.20). This suggests it may represent a second, independent effect on IL-1RA levels. To test this, we entered both SNPs in a regression model and also used the haplotype construction software QTPHASE and WHAP to test the effects of the two alleles of one SNP on the same background chromosome as defined by the second SNP (Table 3 ). The regression analysis showed that both SNPs were associated with IL-1RA levels when correcting for the other: rs4251961, P ¼ 0.02; rs579543, P ¼ 0.03. Haplotype analysis showed that the rs4251961 SNP remains associated with IL-1RA levels when its two alleles fall on the same background chromosome as defined by rs579543 (P ¼ 0.01, Table 3 ). A similar analysis of rs579543 was not consistent with this SNP altering IL-1RA levels independent of rs4251961 (P ¼ 0.08). These results are consistent with rs4251961 or a variant in LD with it, influencing IL-1RA levels but provide inconclusive evidence for or against a separate effect of rs579543, or a variant in LD with it. Table 4 . We restricted analyses to haplotypes occurring at 45% in the InCHIANTI population. Haplotype analyses did not reveal any stronger associations than SNP analyses: the most common haplotype is most strongly associated with IL-1RA levels (P ¼ 5.7 Â 10
À5
) and is almost perfectly tagged by rs4251961.
Correlation of the IL-1RN VNTR variant with HapMap variation
To assess the extent of correlation between HapMap SNPs and the previously reported 86-bp VNTR polymorphism, we amplified this polymorphism in the 90 HapMap-CEPH DNA samples. Out of the 90 HapMap-CEPH samples, only two were found to possess alleles other than the IL-1RA*1 and IL-1RA*2 (corresponding to 4 and 2 86 bp repeats) of the VNTR and were taken out of the LD analysis. Within the 88 individuals informative for the VNTR, allele frequencies of 0.72 and 0.28 were observed for IL-1RA*1 and IL-1RA*2, respectively. We found that this polymorphism is strongly correlated with rs579543 (r 2 ¼ 0.91) and partially correlated with the polymorphism most strongly associated with IL-1RA levels, rs4251961 (r 2 ¼ 0.25).
Effect of IL-1RA serum concentration and genetic variation on other inflammatory markers We found that IL-1RA serum concentrations were associated with various inflammatory markers, including proinflammatory cytokines and acute-phase proteins (Table 5) , some of which have been previously reported in the InCHIANTI study, 6 ,20 but which we record here for comparison with the genetic results. We next tested whether the SNP most strongly associated with IL-1RA levels was associated with these serum proteins. We also included several inflammatory markers not associated with IL-1RA levels. We found nominal associations (Po0.05) between rs4251961 and interferon (IFN)-g (P ¼ 0.03), a-2 macroglobulin (P ¼ 0.008) and IL-1b levels (P ¼ 0.03), although given the number of tests we have performed these results need replication.
Effect of IL-1RA serum concentration and genetic variation on metabolic traits We next investigated the associations between IL-1RA levels, IL-1RA-altering gene variants and metabolic traits. We found that an increase in IL-1RA levels was associated with lower adiponectin levels (P ¼ 1.4 Â 10
À5
), higher body mass index (BMI) (P ¼ 2.2 Â 10 À13 ), higher fasting insulin (P ¼ 7.3 Â 10 À9 ) and higher triglycerides (P ¼ 5.5 Â 10 À14 ) ( Table 5 ). Next, we hypothesized that individuals carrying the minor allele of the rs4251961 SNP (that decreases IL-1RA levels) would be associated with higher adiponectin, lower BMI, lower insulin and lower triglycerides if IL-1RA causally alters these traits. After adjusting for age and sex, we found that carrying an increasing number of rs4251961 C alleles was associated with increasing adiponectin concentrations (P ¼ 0.007) and lower BMI (P ¼ 0.02), but no association with other traits were observed (Table 5) , although the number of traits tested means these associations need replicating. (Similar tests of association of rs579543 are reported in Supplementary  Table 2 ). In addition to the metabolic parameters mentioned above, we did not find any association of rs4251961 with high-density lipoprotein, low-density lipoprotein and total cholesterol levels (data not shown, Po0.05).
Discussion
IL-1 is an important mediator of inflammation that plays a role both for the initiation of an inflammatory response and also a shift to a state of chronic inflammation. There is strong evidence that IL-1 is important in the pathophysiology of arthritis and arteritis. 21 IL-1RA serum levels are correlated with many other important traits related to inflammatory and metabolic disease. The identification of genetic variants within the IL-1RN gene that alter IL-1RA levels will help dissect whether IL-1RA and its counterpart, IL-1, are causally related to these traits.
In this study, we have performed an analysis of common variation across the IL-1RN gene, including assessing correlations with the previously studied intron-2 VNTR with HapMap variants. The majority of previous studies have been limited to the VNTR variant. We have captured a large proportion of variation across the gene and have found that the minor allele of rs4251961, tagging the commonest haplotype, is associated with altered IL-1RA serum concentrations with high statistical confidence (P ¼ 4.9 Â 10 À5 ). We found suggestive evidence that more than one genetic variant in the IL-1RN gene may affect IL-1RA levels. The rs579543 SNP, which is highly correlated with the intron-2 VNTR variant (r 2 ¼ 0.91), was associated with IL-1RA levels in a regression model that included rs4251961 (P ¼ 0.03). Haplotype analysis was consistent with rs579543 having an independent effect on IL-1RA levels but the statistical confidence of this was not strong (P ¼ 0.08) and so further studies are needed to confirm this.
We found that increased IL-1RA concentrations were associated with a range of inflammatory markers and 
Abbreviation: IL-1RA, interleukin-1-receptor antagonist serum concentrations. Haplotype P-values are for individual haplotypes versus all other haplotypes and global value tests the null hypotheses that all five haplotypes confer the same IL-1RA serum concentration.
IL-1RN gene variation and IL-1RA levels S Rafiq et al metabolic measures at nominal levels of statistical significance. We have identified several possible associations between gene variants that alter IL-1RA and these measures, which require robust replications, given that we have not corrected for multiple testing. Most notably, genotypes at rs4251961 that result in low-circulating IL-1RA are associated with increased IL-1b, although the evidence for this was not strong (P ¼ 0.03). We also observed nominal associations between rs4251961 and IFN-g, a-2 macroglobulin, BMI and adiponectin. These results need replicating, given the number of tests we have performed. However, if confirmed, these findings will provide strong evidence that IL-1RA or IL-1 is causally linked to these traits. The potential associations of IL-1RA levels with adiponectin are particularly interesting. Adiponectin, the most abundant protein in adipose tissue, is downregulated by IL-6 and TNF-a and upregulated after targeted weight loss. 22 Polymorphisms within the adiponectin gene are associated with coronary artery disease in type II diabetes patients in a study of Caucasian participants 23 and are strongly associated with secreted adiponectin levels . 24, 25 Our findings are consistent with the evidence that adipose tissue can modulate expression of proinflammatory cytokines although further studies are needed to confirm this. Recently, it was demonstrated that IL-1RN-deficient mice develop a decrease in fat mass. 26 In young Swedish men (18-20 years), it was shown that individuals carrying the IL-1RN VNTR*2 allele had increased total fat mass, as measured by DXA and IL-1RA levels. 15 We did not find any association between rs579543, which tags the VNTR with an r 2 ¼ 0.91, and BMI (Supplementary Table 2 ) although BMI is a far cruder method of measuring fat mass than DXA scans.
In summary, we have found strong evidence that common variation in the IL-1RN gene alters IL-1RA 
Materials and methods

Description of the InCHIANTI study and the intermediate marker measures
The InCHIANTI study is a population-based study of decline in physical functioning in elderly individuals residing in the Chianti geographic region in Tuscany, Italy. The study includes 298 individuals of o65 age and 1155 individuals of age X65 years. The study design and protocol have been described in detail previously. 27 The Italian National Research Council of Aging Ethical Committee approved the study protocol. Serum concentration and other trait measures are described in Table 1 . Blood samples were drawn in the morning after a 12-h overnight fast and after the participants had been sedentary for at least 15 min. The blood collection procedure was performed by a standardized method in order to avoid red cells hemolysis. Plasma and serum aliquots were collected and frozen at À801C until cytokines measurements were performed. Serum IL-6, IL-10, TNF-a and IL-1b levels were measured using immunoassay kits (BioSource Cytoscreen UltraSensitive kits; BioSource International Inc., Camarillo, CA, USA), IL-1RA and IL-6r levels were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits (BioSource cytoscreen human IL-1RA and human sIL-6r kit). IFN-g was determined by a multicytokine-detection system (Bio-Rad, Hercules, CA, USA), which allows detection of concentrations as low as 5 pg/ ml using a Luminex System (Austin, TX, USA). 28 Blood cell counts were performed using a hematology-automated autoanalyzer (SE 9000, DASIT, Sysmex Corporation, Kobe, Japan). The erythrocyte sedimentation rate was measured by a Diesse Ves-Matic automated system reading the end point after 27 min of sedimentation. The results of this system were comparable with those obtained with the Westergren method. Plasma fibrinogen level was automatically determined by a commercially available STA fibrinogen assay (Diagnostic Stago, Roche Diagnostics, GmbH, Mannheim, Germany). Serum CRP (CRP-high sensitivity) was measured in duplicate using ELISA and a colorimetric competitive immunoassay that uses purified protein and polyclonal anti-CRP antibodies. The minimum detectable threshold was 0.03 mg/dl. The inter-assay coefficient of variation (CV) was 5. Plasma insulin was determined by a commercial double-antibody, solid-phase radioimmunoassay (Sorin Biomedica, Milan, Italy) intra-assay CV was 3.1 þ 0.3%. Serum a-2 macroglobulin concentration was measured using an immunoturbidimetric assay (Roche Diagnostics, GmbH, Mannheim, Germany) and a modular P800 Hitachi autoanalyzer. Serum glucose and triglyceride levels were automatically determined by enzymatic colorimetric assays (Roche Diagnostics, GmbH) and a Roche-Hitachi 917 autoanalyzer. The intra-assay CV was 0.9%, the interassay CV was 1.8% for glucose and 3.1 and 1.8% for triglycerides. Serum levels of adiponectin were measured using an radioimmuno assay (Human Adiponectin RIA Kit, Linco Research Inc, MO, USA), minimum detectable threshold was 1 ng/ml, intra-assay CV was 1.78-6.21% and interassay CV was 6.9-9.25.
Genotyping and PCR
We first performed whole genome amplification, including 6% duplicate samples. We used the modified Taqman assays at Kbiosciences (Hoddesdon, UK) to generate genotypes from SNPs for all samples including duplicates. Genotyping for rs579543 and rs973635 was performed in-house using conventional Taqman probes (Applied Biosystems, Foster City, CA). DNA samples for amplifying the 86-bp VNTR in the intron-2 of IL-1RN were obtained from the HapMap-CEPH project. The 86 bp VNTR polymorphism in the intron-2 region of IL-1RN was amplified as described previously 29 except with the use of an alternate reverse primer (5 0 -CCATG-GATTCCCAAGAACA-3 0 ) after we found possible allele dropout of the VNTR allele-2 owing to the presence of SNPs within the primer-binding site of the published primers. Briefly, 4 ml of DNA from each individual at 5 ng/ml concentration was amplified in a 15-ml PCR, which consisted of initial denaturation at 961C for 1 min followed by 35 cycles of 1 min at 941C, 1 min at 601C, 1 min at 701C and finally 5 min at 701C. Two percent agarose gel was used to view ethidium bromide-stained DNA samples under UV light.
Genetic analysis
For this study, we used data from HapMap phase II NCBI B34 assembly to select an optimum number of tagging SNPs to capture a large amount of variation across the IL-1RN gene and 7.5 kb either side of the gene (31.12 kb region). Only SNPs with MAF 410% were selected for this study. Eight SNPs were selected as tags that capture 84% of other HapMap SNPs at an r 2 40.8 in Caucasian Europeans. LD patterns were assessed using Haploview version 3.3. Extent of LD was measured as r 2 .
Statistical analysis
For SNP analysis, we used STATA version 9.1. (Statacorp, College Station, TX, USA) and for haplotype analysis we used WHAP software v2.09 (http://pngu.mgh.harvard. edu/purcell//whap/) and QTPHASE from the UN-PHASED suite of programs. 30 Standardizd Z-scores of IL-1RA levels were used for haplotype analysis in WHAP. All non-normally distributed variables, including serum IL-1RA concentrations, were log-transformed and all genotype association analyses were corrected for age and sex. Linear regression was used to test for association of the three genotypes at each SNP with serum IL-1RA concentrations and other continuous traits. Serum concentrations of IFN-g, IL-10, TNF-a and IL-1b were low and below the desirable detectable limit, as described previously, 20 in 78, 63, 55 and 63% of individuals, respectively. Hence, we analyzed the association of these variables with independent genotypes and IL-1RA concentrations in ordered logistic regression models, after distributing the dependent variables in quantiles using STATAv9. We used the xtile command in STATA v9 to split values into quintiles. This attempts to split values into quintiles but may automatically result in the creation of different numbers of quantiles depending on the number of subjects with low values for different markers. Our study had 480% power at P ¼ 0.05 to detect standard deviation differences of 0.2 in continuous traits, given minor allele frequencies 410%.
